A detailed history of Vinva Investment Management LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Vinva Investment Management LTD holds 98,403 shares of BMRN stock, worth $5.39 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
98,403
Previous 31,094 216.47%
Holding current value
$5.39 Million
Previous $1.72 Billion 209.87%
% of portfolio
0.1%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$52.62 - $61.93 $3.54 Million - $4.17 Million
67,309 Added 216.47%
98,403 $5.32 Billion
Q2 2025

Aug 12, 2025

BUY
$54.08 - $68.32 $1.12 Million - $1.41 Million
20,620 Added 196.87%
31,094 $1.72 Billion
Q1 2025

May 13, 2025

BUY
$61.25 - $72.83 $641,532 - $762,821
10,474 New
10,474 $748 Million
Q1 2023

May 11, 2023

BUY
$87.74 - $117.27 $227,071 - $303,494
2,588 New
2,588 $247 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Vinva Investment Management LTD Portfolio

Follow Vinva Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vinva Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Vinva Investment Management LTD with notifications on news.